Sabra Health Care REIT, Inc.
SBRA
$17.87
$0.412.35%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 385.76M | 381.50M | 378.46M | 376.99M | 372.17M |
Total Other Revenue | 335.39M | 322.04M | 304.76M | 289.00M | 278.11M |
Total Revenue | 721.15M | 703.54M | 683.22M | 665.99M | 650.28M |
Cost of Revenue | 232.42M | 226.52M | 216.32M | 207.12M | 201.70M |
Gross Profit | 488.73M | 477.02M | 466.90M | 458.87M | 448.59M |
SG&A Expenses | 50.91M | 50.07M | 53.71M | 52.07M | 48.86M |
Depreciation & Amortization | 170.20M | 169.62M | 170.19M | 170.71M | 173.17M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 453.53M | 446.21M | 440.23M | 429.91M | 423.73M |
Operating Income | 267.62M | 257.33M | 243.00M | 236.09M | 226.55M |
Income Before Tax | 141.73M | 127.72M | 98.29M | 54.12M | 51.22M |
Income Tax Expenses | 965.00K | 1.01M | 1.12M | 1.84M | 1.73M |
Earnings from Continuing Operations | 140.76 | 126.71 | 97.17 | 52.28 | 49.50 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 140.76M | 126.71M | 97.17M | 52.28M | 49.50M |
EBIT | 267.62M | 257.33M | 243.00M | 236.09M | 226.55M |
EBITDA | 432.95M | 422.09M | 407.37M | 400.98M | 393.91M |
EPS Basic | 0.60 | 0.54 | 0.42 | 0.23 | 0.21 |
Normalized Basic EPS | 0.41 | 0.38 | 0.34 | 0.32 | 0.30 |
EPS Diluted | 0.59 | 0.53 | 0.41 | 0.21 | 0.20 |
Normalized Diluted EPS | 0.41 | 0.38 | 0.34 | 0.32 | 0.30 |
Average Basic Shares Outstanding | 940.40M | 933.96M | 928.59M | 925.52M | 925.11M |
Average Diluted Shares Outstanding | 950.73M | 943.80M | 937.36M | 931.54M | 930.03M |
Dividend Per Share | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |
Payout Ratio | 200.39% | 221.09% | 286.65% | 531.00% | 560.72% |